|
Volumn 2, Issue 2, 2001, Pages 123-136
|
Transcriptional profiling in cancer: The path to clinical pharmacogenomics
a |
Author keywords
Cancer classification; Class discovery prediction; Gene expression profiling; Genetics; Human; Microarrays; Molecular classification methods; Neoplasms classification genetics; Pharmacogenomics predictive pharmacology; Toxicogenomics predictive toxicology
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
COMPLEMENTARY DNA;
FLUOROURACIL;
GYRASE INHIBITOR;
PROTEIN TYROSINE PHOSPHATASE;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
CANCER CELL CULTURE;
CANCER CLASSIFICATION;
CANCER THERAPY;
CAUSE OF DEATH;
DEVELOPED COUNTRY;
DNA MICROARRAY;
DRUG RESPONSE;
ETIOLOGY;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
MEDICAL TECHNOLOGY;
MORBIDITY;
PHARMACOGENOMICS;
PREDICTION;
REVIEW;
ANIMALS;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
NEOPLASMS;
PHARMACOGENETICS;
TRANSCRIPTION, GENETIC;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0035020425
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.2.2.123 Document Type: Review |
Times cited : (35)
|
References (61)
|